Skip directly to content

R&D Solutions

Scopus Case Study: Finding the best scientific minds to partner with

on Mon, 06/19/2017 - 20:35

Having access to a robust network of experts provides companies with a leg up in pursuing the most innovative approaches to drug discovery. When exploring uncharted territories such as new therapeutic areas or new molecules, the most competitive companies tap into the best minds in science that will guide them to the right experts to collaborate with and which avenues to pursue. This is where comprehensive access to literature and research trends matters.

“For midsize companies to compete with larger companies that have greater resources, it’s all about agility and creating the most innovative approaches.”

– Calliope Saito, Pharmaceutical R&D Executive

In a recent case study, an R&D executive at a midmarket pharma company describes how her team’s efforts to move compounds successfully through the pre-clinical phase often requires identifying and leveraging external expertise.

Gaining a competitive advantage with Scopus: a case study for pharma

on Fri, 04/14/2017 - 15:39

Getting a new drug to market as fast — and as safely — as possible is a key focus for any researcher or developer manager at a pharmaceutical company, regardless of size.

In such a competitive environment, facing a delay of just a few months can give a rival company the chance to get to market first, so it is important that your drug moves through every step, from trials to approval, at top speed. However, in drug development, where drug failure rates have become a challenge, you have to not only account for speed, but also the thoroughness and quality of the data you use to make the right decisions at every stage of development.

“Anything that can shorten our timelines and reduce drug failure rates gives us a competitive advantage.” — Mark Collin, Medical Affairs Executive

In the earlier discovery stages, a researcher who is able to efficiently tap into current research and scientific trends in different therapeutic

How researchers at R&D organizations use Scopus to overcome challenges

on Wed, 02/01/2017 - 22:52

Contributed by: Alexandra Kahn

To better understand how Scopus helps to support research and development outcomes, and pass that information along to you, we recently surveyed R&D organizations that use Scopus.

Whether to stay abreast of scientific developments, develop new ideas quicker, keep ahead of the competition, or find key experts and opinion leaders, organizations have found Scopus enables their R&D researchers to overcome industry challenges.

In this post, we focus on 2 key ways Scopus is making a difference for researchers in the R&D industry.

Finding key experts

A key benefit of Scopus repeatedly expressed was the ability to find the right experts working in a specific area of interest. A few of the comments relating to this included:

“We were faced with a technical problem where we didn't have the competencies internally.

Webinar: How Unilever uses SciVal to help accelerate innovation

on Wed, 02/17/2016 - 19:14

“Scopus helps us do more “E-Science” – scientific investigation that can be undertaken more effectively, less expensively, and without having to perform work in the lab that has already been done by others or that isn’t likely to produce relevant outcomes.”

— David Younghusband, Information Systems Specialist, Unilever R&D

The Unilever Information Team uses SciVal, which is underpinned by Scopus data, to help accelerate innovation and boost competitiveness. The advanced analytics and supercomputer technology of SciVal allows them to build a variety of perspectives into research performance and address such challenges as:

  • Finding technology partners
  • Measuring against the competition
  • Identifying emerging technology areas.  

The SciVal team invites you to join an interactive webinar in which the Unilever information team will share how SciVal helps them to solve these challenges.

Register now

  • Date: Thursday Feb 25
  • Time: 15:00 – 15:30 GMT

Case Study: Scopus improves product development outcomes

on Tue, 04/14/2015 - 13:44

Scopus is the choice of preference for more than 3,000 academic, government and corporate institutions. This is what James, a research pathologist for a medical device manufacturer who works with Scopus on a regular basis, told us about his experience.

James is an experienced research pathologist for a medical device manufacturer, busy with at least 10 projects at any given time. His contribution to product development ranges from shaping early stage proof-of-concept work to preparations for submission to regulatory authorities. The common denominator for him is to understand disease states and product impacts on the body.

James spends about 20% of his time on large, breakthrough innovation projects on a team dedicated to uncovering new ideas. The product innovation process starts with discussing approaches and capabilities for addressing a problem.